What? Nothing to compare to Elmiron, owned by Johnson and Johnson and sold by J+J. Different delivery, different prescription and dosage time and product. That's a different situation.
Good luck figuring out royalties until we have some info on how negotiations are being conducted. And remember that there will be a few products from PAR, and the same pharma might not be the only one sending royalties to PAR.
Potential Financial Implications of Yesterday's Results, page-75
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $73.55M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.0¢ | $216.0K | 1.057M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 143324 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 44935 | 3 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |